Dexamethasone FDA label update (2026-07-17)

What To Know

This DailyMed label update provides the formal, regulatory prescribing information for dexamethasone, including indications, dosing ranges, and guidance on tapering.

The label explicitly mentions use "to tide the patient over a critical period of the disease in regional enteritis and ulcerative colitis," which is why this is relevant to people with Crohn's disease or ulcerative colitis who may encounter systemic corticosteroid treatment.

The label includes dosing examples, pediatric dosing ranges, equivalent-dose tables comparing dexamethasone to other corticosteroids (prednisone, hydrocortisone, methylprednisolone, etc.), and administration notes for specific situations (e.g., cerebral edema, acute allergic reactions).

It is not a clinical-practice guideline; it is the drug's official FDA prescribing information and should be interpreted alongside a clinician's judgment and current specialty guidance.